✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchRare Diseases Why This Matters Rescheduling cannabis from Schedule I to a lower DEA schedule...
Cannabinoid Therapies in Less-Common Disorders: Clinical Evidence and Formulation Strategies.
CED Clinical Relevance #56Monitored Relevance Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch | CED Clinic Rare DiseasesClinical ReviewFormulationEvidence-Based MedicineIndividualized Medicine JournalDiseases (Basel, Switzerland)Study TypeClinical StudyPopulationHuman participants Why This MattersThis review addresses...